Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Hannes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Diagnosis & Therapy|September 21, 2022
Digital PCR-Based Method for Detecting CDKN2A Loss in Brain TumoursShlomo Tsuriel, Victoria Hannes, Asala Hasona, et al.
Genes|August 27, 2021
Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon CancerKavita Thakur, Manu Smriti Singh, Sara Feldstein-Davydova, et al.
Biomolecules|September 28, 2023
Mutated <i>TP53</i> in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma PatientsLiyona Kampel, Sara Feldstein, Shlomo Tsuriel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2023
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 StudyNir Peled, Laila C Roisman, Esther Levison, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Diagnosis & Therapy|September 21, 2022
Digital PCR-Based Method for Detecting CDKN2A Loss in Brain TumoursShlomo Tsuriel, Victoria Hannes, Asala Hasona, et al.
Genes|August 27, 2021
Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon CancerKavita Thakur, Manu Smriti Singh, Sara Feldstein-Davydova, et al.
Biomolecules|September 28, 2023
Mutated <i>TP53</i> in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma PatientsLiyona Kampel, Sara Feldstein, Shlomo Tsuriel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 16, 2023
Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 StudyNir Peled, Laila C Roisman, Esther Levison, et al.
Pageof 1